Lexiscan: Clinical Trials

9 trials of Lexiscan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 recruiting, 1 unknown. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Completed 7, Recruiting 1, Unknown 1

Follow Lexiscan: new trials by email Literature Review of Lexiscan trials Research Report on Lexiscan

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Allograft Dysfunction in Heart Transplant
Regadenoson - Heart Transplant Failure and Rejection
Phase 4RecruitingPaul Kim3762019-10-012026-05-01
Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction
Regadenoson, Gadolinium, Cardiac MRI - Heart Transplant, Acute Graft Rejection
Phase 4CompletedPaul Kim142015-11-012017-08-22
Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging
Regadenoson - Coronary Artery Disease
Phase 4CompletedTimothy M. Bateman402014-09-032018-09-19
Characterization of Myocardial Blood Flow Measurements Using Lexiscan®™ (Regadenoson) (Lexiscan®™) Rubidium-82 Myocardial Perfusion PET: A Temporal-Dependency Investigation
Regadenoson, Rubidium-82 - Myocardial Blood Flow Reserve
Phase 4CompletedTimothy M. Bateman, MD802013-07-012018-08-16
Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson
Regadenoson - Ischemic Heart Disease
Phase 4CompletedWashington University School of Medicine162013-01-012018-06-15
Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease
regadenoson - Coronary Artery Disease
Phase 4UnknownDipan Shah502011-08-012017-10-03
Stress Testing and Cardiac Magnetic Resonance
regadenoson - Coronary Disease
Phase 4CompletedUniversity of Chicago202009-04-012021-07-12
A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment
Regadenoson, Placebo - Kidney Diseases, Coronary Artery Disease
Phase 4CompletedAstellas Pharma Inc5112009-04-012012-05-18
A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease
Regadenoson, Placebo - Asthma, Coronary Artery Disease
Phase 4CompletedAstellas Pharma Inc10092009-04-012012-09-18

Conditions studied

Coronary Artery Disease (4)  ·  Asthma (1)  ·  Coronary Disease (1)  ·  Kidney Diseases (1)  ·  Myocardial Ischemia (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Rejection, Psychology (1)  ·  Renal Insufficiency (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

Astellas Pharma Inc (2)  ·  Paul Kim (2)  ·  Dipan Shah (1)  ·  Timothy M. Bateman (1)  ·  Timothy M. Bateman, MD (1)  ·  University of Chicago (1)  ·  Washington University School of Medicine (1)

Countries

United States (9)

Top investigators

Timothy M Bateman, MD (2)  ·  Amit Patel, M.D. (1)  ·  Dipan Shah, M.D. (1)  ·  Pamela K Woodard, MD, BA (1)  ·  Paul J Kim, MD (1)  ·  Paul Kim, MD (1)

Results publications

PMID 11693758, PMID 11943259, PMID 16890123, PMID 18551063, PMID 19284612, PMID 20413602, PMID 20643330, PMID 21555100, PMID 21962016, PMID 22484721, PMID 23272658, PMID 24355800, PMID 24457279, PMID 3308166